O
Ocular Therapeutix
Biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye
At a glance
- Status
- Listed
- Listing
- IPO 2014
News
Open roles
Ocular Therapeutix in the Bedford ecosystem
The Ocular Therapeutix office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later15 investors entered at this stage
- GPGreat Point Partners
- APAcuta Capital Partners
Versant Ventures- AVAscension Ventures
- SISV Health Investors
- OMOpaleye Management
- DCDeep Track Capital
- BIBaxter International
- ASAscension
- TCTCGX
- LCLogos Capital
Polaris Partners- SCSurveyor Capital
- VPVenrock Healthcare Capital Partners
Perceptive Advisors
Source: Dealroom Talent Intelligence.
Alumni founders
Former Ocular Therapeutix employees who went on to found companies, sorted by Dealroom signal score.
Fred KhosraviUnited States
HBhC BioscienceEst. 2021
Leslie WilliamsUnited States
PTPandion TherapeuticsEst. 2016
Brian KennedyUnited StatesGlobal footprint
Patents
34 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
See Ocular Therapeutix on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
